Amanote Research
Register
Sign In
Php33 - Understanding the Japanese Policy Initiatives and the Patient Characteristics of Rare, Intractable Diseases
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.929
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
H.R. KIM
B. Crawford
Publisher
Elsevier BV
Related search
Understanding the Pathophysiology and Searching for Biomarkers for Rare Genetic Developmental Diseases
Proceedings
Characteristics and Enlightenment of Japanese Policy Evaluation Method
Open Journal of Legal Science
Policy Initiatives for Health and the Bioeconomy
OECD Science, Technology and Industry Policy Papers
The Japanese Smart Grid Initiatives, Investments, and Collaborations
International Journal of Advanced Computer Science and Applications
Computer Science
Erratum to : Research Committees and Their Reports on Intractable Diseases Specified by the Japanese Ministry of Health and Welfare
Igaku Toshokan
Approval of the Patient Care Line With Rare Diseases, Brazil’s Portaria 199 and Its National Policy. What Does That Mean? What Changes?
Revista de Medicina da UFC
Treatment and Care of Intractable Neurological Diseases
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Understanding the Japanese Mind.
Archives of Internal Medicine
Characteristics of Patients Contacting a Center for Undiagnosed and Rare Diseases
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology